Latest Biotechnology, Pharmaceutical and Healthcare News

13:50 EST 4th March 2015 | BioPortfolio

Showing News Articles 1–25 of 400,000+

Wednesday 4th March 2015

Logic PD's Bill Betten to Lead Discussions on Big Data at Frost & Sullivan Medical Technologies 2015

Logic PD, a product innovation and realization company for connected devices, announced today that Logic PD’s Vice President of Business Solutions for Medical and Life Sciences, Bill Betten will lead two sessions at the

Law Firms Weil Quaranta and Babbitt Johnson File Federal Class Action against Lumber Liquidators in Wake of ’60 Minutes’ Report

The law firms Weil, Quaranta, P.A. of Miami and Los Angeles and Babbitt & Johnson, P.A. of West Palm Beach have filed a federal class action suit against Lumber Liquidators for selling Chinese-made laminated wood floors containing dangerous levels of toxic formaldehyde. The 16-page suit followed a March 1 “60 Minutes” report about the ...

Home Care Medical Sheboygan Retail Store to Host CPAP and Wheelchair Tune-up Clinic

Home Care Medical, Inc. one of Wisconsin’s largest and most respected providers of home medical equipment, rehab technology, and respiratory care is pleased to host a CPAP and Wheelchair Tune-up Clinic on Friday, March 6, 2015 at Home Care Medical’s Sheboygan Retail Store, 2922 South Business Drive in Sheboygan, Wisconsin. New Berlin, Wisconsin (PRWEB) March 04, 2015 Home Care Medical, Inc. o...

Emulate’s Organs-on-Chips Receive Recognition for Innovative Design

Technology Nominated for Design of Year Award, To Be Featured in Exhibitions at MoMA in New York and Design Museum in London Emulate, Inc., today announced that the company’s Organs-on-Chips technology has been recognized by two international museums in exhibitions that showcase original creations that exemplify innovative design. The Organs-on-Chips...

Scientist-industry partnerships do not constitute a "tangled web"

The Medical Research Council encourages health scientists to form strategic research partnerships with industry, not least to accelerate the translation of research into public benefit. MRC also...

Surgeon in female genital mutilation case should not have been prosecuted

Having read the statement from the Royal College of Obstetricians and Gynaecologists and the press reports about the acquittal of Dhanuson Dharmasena,1 2 3 I am surprised that Dr Dharmasena’s actions...

Hugh Baron

bmj;350/mar04_11/h1025/FIG1F1fig1Hugh Baron with his daughter, Susannah BaronJeremy Hugh Baron—a gastroenterologist with eclectic interests—described himself as a “restless polymath” whose recreation...

Dharmasena case: responsibility takes precedence over accountability

Twelve months ago I welcomed Dhanuson Dharmasena into my research team having ascertained his innocence. A rigorous trial has exonerated this decent doctor.1In 2012 Dr Dharmasena faced an emergency...

Tufts Health Plan and Granite Healthcare Network to Launch New Hampshire-based Health Insurance Company, Tufts Health Freedom Plan

First of its kind joint venture in New Hampshire between a health insurance company and health systems to bring high-quality, cost-effective, accessible care to members Combining clinical expertise and a focus on population health management with market leading insurance products and provider network designs, Tufts Health Plan, ranked the No. 1 health ...

Stallergenes mulls merger with Greer

The combined business would be owned by Ares Allergy Holding, the English subsidiary of Ares Life Sciences, with shares listed on EURONEXT Paris, though Ares confirmed that "there is no intention to change the established Stallergenes brand." Ares Li...

Baxter acquires SuppreMol for innovative approach to autoimmune disease

Baxter's Bioscience Business has acquired SuppreMol for €200m in what the privately-held German firm's CEO called "a good day for both companies."

Immune oncology central to Merck KGaA's pharma growth hopes

Merck KGaA is hoping to climb the pharma ranks in the next few years through the development of its pipeline and the overall makeover of the business. Comments by the chair of the firm's executive board, Dr Karl-Ludwig Kley, during the firm's annual....

BRIEF-Luz Saude SA FY net profit up 29 pct to 18.1 mln euros

March 4 (Reuters) - Luz Saude SA (formerly Espirito Santo Saude SA) :

UPDATE 6-U.S. Supreme Court divided over Obamacare challenge

WASHINGTON, March 4 (Reuters) - The U.S. Supreme Court appeared divided on ideological lines on Wednesday as it heard a second major challenge to President Barack Obama's healthcare law targeting tax subsidies intended to help people afford insurance...

Quanterix Expands Kevin Hrusovsky’s Role to CEO

Life Science and Diagnostics Veteran to lead Quanterix in Driving Growth of its Disruptive Technology Quanterix Corporation (“Quanterix”), a leader in ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Kevin Hrusovsky as Chief Executive Officer (“CEO”). Mr. Hrusovsky will contin...

Behind the scenes of medicines regulation

Sir Michael Rawlins talks about how the MHRA intends to speed up approval of innovative medicines, involve pharmacists in reclassification and address drug shortages and trade in counterfeit medicines.

Scientists Find Clues to Cancer Drug Failures

Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.Read more about Scientists Find Clues to Cancer Drug Failures

Morecambe midwives became 'victims' of 'closed' culture, warns Kirkup

Midwives who failed to raise concerns at Furness General Hospital let both themselves and families down and became “victims” of the “closed” culture that they had helped to create, the chair of an inquiry into the trust has told Nursing Times.

Illinois Boy’s Rare Disorder Leads to Epic Fix by Pediatric Heart Surgery Pioneer at Lucile Packard Children’s Hospital Stanford

* Jordan Ervin had 26 areas of blood flow blockage from his heart to his lungs * Surgeon Frank Hanley repaired all of the blockages in one marathon surgery this past December * Disorder affects just 1 in 10,000 people worldwide The first five years of life for Jordan Ervin were an endless cycle of illnesses and medical appointm...

eMagin Corporation Fourth Quarter 2014 Earnings Conference Call to be Held on Thursday, March 12, 2015

eMagin Corporation (NYSE MKT:EMAN) will release fourth quarter 2014 earnings and host a conference call that will be webcast on Thursday, March 12, 2015. The Company's CEO, Andrew G. Sculley and its CFO, Paul C. Campbell, will discuss financial results for the fourth quarter of 2014, ended December 31, 2014, and provide a corporate update. The con...

Attendance for Oxford Global’s Successful Biotherapeutics Series Shows Overwhelming Popularity for 2015

Oxford Global’s marketing and sales campaign for The Biotherapeutics Series has brought about a record number of registration enquiries. Senior level attendees from big pharma, smaller biotech companies and academic research institutions have already reserved their place across the 2 days, to contribute to high level scientific discussion with like minded peers. Taking place on 20-21 April ...

UPDATE 2-Slash sugar intake to fight obesity, tooth decay - WHO

* Can of soda contains 10 teaspoons of sugar (Adds detail, quotes from news briefing)

Liberia Calls for Ebola 'Marshall Plan' to Rebuild Economies

Read more

Fat transfer co Tulip reports positive trial results

The Israeli company is developing a pill that expands in the stomach, inflates like a balloon, and creates a sense of satiety.

Transgenomic Announces Closing of Public Offering of Common Stock

Transgenomic, Inc. (NASDAQ: TBIO) today announced the closing of its underwritten public offering of 3,573,899 shares of the company’s common stock and corresponding warrants to purchase 714,780 shares of the company’s common stock. The common stock and corresponding warrants were sold in combination, with one warrant to purchase 0.20 of a share of co...


Search BioPortfolio:
Loading
Advertisement
Advertisement

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.